491
Downloads
12
Episodes
This is the monthly podcast of ACCRU, designed to tell the stories behind the innovative research of our members. Our mission is to establish the next level study for cancer research across the major disease groups. We promise our members the resources and collaboration to conduct innovative trials that transform patient care.ACCRU stands for ”Academic and Community Cancer Research United.”
Episodes
Friday Apr 01, 2022
Friday Apr 01, 2022
In this episode, podcast host Dr. Ciara O’Sullivan interviews Dr. Catherine Diefenbach about her innovative research for relapsed mantle cell lymphoma. Dr. Diefenbach is currently director of hematology translational research as well as director of the Clinical Lymphoma Program at NYU’s Langone Perlmutter Cancer Center. Dr. Diefenbach discusses a current ACCRU study that has the potential to prolong the survival of R/R MCL patients, including BTK inhibitor-resistant patients, or even have a role in the frontline treatment of elderly or unfit patients who are ineligible for aggressive chemo-immunotherapy.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.